Zhi Dong Pan
Directeur/Bestuurslid bij MabPlex International Co., Ltd.
Profiel
Zhi Dong Pan is currently a Director at MabPlex International Co., Ltd.
He previously served as a Member-Supervisory Board at Dalian Huarui Heavy Industry Group Co., Ltd.
He earned a doctorate degree from Dalian Maritime University in 2017.
Actieve functies van Zhi Dong Pan
| Bedrijven | Functie | Begin |
|---|---|---|
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Directeur/Bestuurslid | 01-03-2020 |
Eerdere bekende functies van Zhi Dong Pan
| Bedrijven | Functie | Einde |
|---|---|---|
| DALIAN HUARUI HEAVY INDUSTRY GROUP CO., LTD. | Directeur/Bestuurslid | - |
Opleiding van Zhi Dong Pan
| Dalian Maritime University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DALIAN HUARUI HEAVY INDUSTRY GROUP CO., LTD. | Non-Energy Minerals |
| Bedrijven in privébezit | 1 |
|---|---|
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
